Physician profile
Stuart L Phillips
NPI 1275763823
$1,788.20
in general payments reported to CMS, 2019-2025
18 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $197 · 2021: $367 · 2022: $246 · 2023: $109 · 2024: $415 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $719.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $334.58 | 2019-2025 | Eliquis, Camzyos |
| Pfizer INC. | $261.27 | 2020-2025 | |
| Lexicon Pharmaceuticals, INC. | $216.76 | 2024 | Inpefa |
| Abbvie INC. | $182.46 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $124.01 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $111.79 | 2019-2022 | |
| Vifor Pharma, INC. | $101.75 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $77.35 | 2019-2022 | |
| Mylan Specialty L.P. | $75.81 | 2019-2024 | Yupelri |
| Boston Scientific Corporation | $56.86 | 2025 | Watchman Access System |
| Allergan, INC. | $56.06 | 2020 | |
| Mallinckrodt Hospital Products INC. | $43.48 | 2024 | Terlivaz |
| Csl Behring | $33.89 | 2020 | |
| Melinta Therapeutics, LLC | $31.06 | 2022-2024 | Rezzayo |
| Kiniksa Pharmaceuticals International, Plc | $29.41 | 2024 | Arcalyst |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $22.12 | 2020 | |
| Portola Pharmaceuticals, LLC | $15.57 | 2019 | |
| Amgen INC. | $13.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.